Lipoprotein(a), or Lp(a), is a protein that transports cholesterol in the blood. High levels of Lp(a) in the blood can increase the likelihood of plaques or blood clots forming in the arteries.

This new perspective creates opportunities to innovatively address lipoprotein alterations and associated risks. The study was conducted as an observational cohort study at Sant Pau Hospital ...

For people who quit after drinking 1.5 drinks per day or less, their LDL rose 1.10 mg/dL, and their HDL fell by 1.25 mg/dL.

The core of the lipoprotein, containing cholesterol ester and TG, is nonpolar and hydrophobic, and the outer layer of the lipoprotein particle (containing free cholesterol, phospholipid ...

New research suggests that changes in alcohol consumption significantly impact cholesterol levels, raising questions about ...

A new study published in the Journal of American Medical Association showed that the innovative small interfering RNA (siRNA) medication olpasiran (Amgen) can effectively reduce lipoprotein(a) ...

The RNA inhibitor reduces levels of oxidized phospholipids, which are presumed to promote atherosclerosis, by more than 93%.

Lp(a) is a lipoprotein that travels through the blood. Elevated levels of Lp(a) collect in the arteries, gradually narrowing them and limiting blood supply to the heart, brain, kidneys and legs.

2 Department of Movement Sciences, Maastricht University, Maastricht, the Netherlands 3 Department of Endocrinology, University Hospital Groningen, Groningen, the Netherlands Correspondence to: Dr ...